Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish
Farmovs
In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19. 

The trial is expected to include more than 45 countries worldwide, including a number of South African sites. 

Farmovs

FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.   

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients. 

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.  FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.


News Archive

KovsieTennis wins gold at USSA – again
2014-12-10

The annual University Sport South Africa (USSA) tournament was hosted by the KovsieTennis Club from 1 – 5 December 2014 in Bloemfontein.

This year was the first time that KovsieTennis entered two teams in the tournament. Our first team played in section A, while our second team competed in section B. Both sections were divided into two pools with round robin matches during the first three days. Thursday presented the cross-over with the finals taking place on that Friday.

During the round robin phase, our first team beat Rhodes University, University of Witwatersrand and University of Pretoria. On the Thursday, they met North West University (Pukke) in the semi-final and beat them 8-5 in matches. The last match was not played, since Kovsies already won the semi-final. For the third year in a row, Kovsies faced Stellenbosch University (Maties) in the final. After some brilliant tennis in sweltering heat, Kovsies found themselves 7-5 down in matches with the last two mixed doubles still to be played.

Janine Erasmus and Duke Munro, as number one couple, and Arne Nel and Heidi Murray, as number two couple, played outstanding mix doubles to win both matches, tying the score on 7-7. Due to the fact that Kovsies lost three of their matches in three sets they were crowned champions, winning with 17-14 on sets.

It is the eighth year in a row that the Kovsie club managed to win gold during USSA. We are also the only team that has won the tournament since the format changed to combined teams from 2010.

After the tournament Arne Nel, Duke Munro and Christi Potgieter were included in the squad from which a team will be selected, should tennis feature at the World Student Games in Korea during July 2015. Janine de Kock , KovsieTennis manager, was also appointed as manager of the SA Student team and Marnus Kleinhans from Kovsies will be their coach.

The second team beat Tshwane University of Technology, University of Kwa-Zulu- Natal and University of Cape Town during the round robin and in the semi-finals they won against University of Pretoria. Unfortunately they lost in the final against the North West University, but the club is extremely proud of the players since it was the first time all of them played in a USSA tournament. They gained a lot of experience that will greatly contribute to the value they will add to the team next year.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept